Peptidases in human bronchoalveolar lining fluid, macrophages, and epithelial cells: Dipeptidyl (amino)peptidase IV, aminopeptidase N, and dipeptidyl (carboxy)peptidase (angiotensin-converting enzyme)

Journal of Laboratory and Clinical Medicine

Volumn 130, Issue 6, 1997, Pages 603-614

  Juillerat Jeanneret, Lucienne ^a   Aubert, John David ^b   Leuenberger, Philippe ^b  

^a UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031460850     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90110-4     Document Type: Article

References (33)

1. Kenny AJ, O'Hare MJ, Gusterson BA. Cell-surface peptidases as modulators of growth and differentiation. Lancet 1989;2:785-7.
2. Kenny AJ, Bourne A. Cellular reorganisation of membrane peptidases in Wallerian degeneration of pig peripheral nerve. J Neurocytol 1991;20:875-85.
3. Cooper PH, Mayer P, Baggiolini M. Stimulation of phagocytosis in bone-marrow derived mouse macrophages by bacterial lipopolysaccharide: correlation with biochemical and functional parameters. J Immunol 1984;133:913-22.
4. Koito A, Hattori T, Murakami S, et al. A neutralizing epitope of human deficiency virus type 1 has homologous aminoacid sequence with the active site of inter-a-trypsin inhibitor. Int Immunol 1989;1:613-8.
5. O'Brien RF, Cohn DL. Serum angiotensin converting enzyme levels in AIDS. Chest 1990;97:1021-2.
6. Kozlovski S, Corr M, Takeshita T, et al. Serum angiotensin-I converting enzyme activity processes a human immunodeficiency virus-1 gp160 peptide for presentation by major histocompatibility complex class I molecules. J Exp Med 1992; 175:1417-22.
7. Luisetti M, Piccioni PD, Donnetta AM, Bulgheroni A, Peona V. Protease-antiprotease imbalance: local evaluation with bronchoalveolar lavage. Respiration 1992;59:24-7.
8. Reddel RR, Ke Y, Gerwin BI, et al. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transformation via strontium phosphate coprecipitation with a plasmid containing SV40 early region gene. Cancer Res 1988;48:1904-9.
9. Klech H, Pohl W. Technical recommendations and guidelines for bronchoalveolar lavages (BAL). Eur Resp J 1989;2: 561-85.
10. Juillerat-Jeanneret L, Aguzzi A, Wiestler OD, Darekar P, Janzer RC. Dexamethasone selectively regulates the activity of enzymatic markers of cerebral endothelial cell lines. In Vitro Cell Dev Biol 1992;28A:537-43.
11. Juillerat-Jeanneret L. Modulation of proteolytic activity in tissues following chronic inhibition of angiotensin-converting enzyme. Biochem Pharmacol 1993;45:1447-54.
12. Juillerat L, Nussberger Y, Ménard J, Mooser V, Christen Y, Waeber B, et al. Determinants of angiotensin II generation during converting enzyme inhibition. Hypertension 1990;16:564-72.
13. Danilov SM, Jaspard E, Churakova T, et al. Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. J Biol Chem 1994;269:26806-14.
14. Schullek JR, Wilson IB. Angiotensin converting enzyme: substrate inhibition. Peptides 1989;10:431-4.
15. Weisser K, Scloos J. Measurement of serum ACE activity in vitro after administration of enalapril in man cannot reflect inhibition of the enzyme in vivo. Methods Find Exp Clin Pharmacol 1993;15:413-8.
16. Dragovic T, Igic R, Erdös EG, Rabito SF. Metabolism of bradykinin by peptidases in the lung. Am Rev Respir Dis 1993;147:1491-6.
17. Specks U, Martin WJ, Rohrbach MS. Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases. Am Rev Respir Dis 1990;141:117-23.
18. Lindgren BR, Andersson RGG. Angiotensin-converting enzyme inhibitors and their influence on inflammation, bronchial reactivity and cough. Med Toxicol Adverse Drug Exp 1989;4:369-80.
19. Lieberman J. Elevation of serum angiotensin-converting enzyme (ACE) in sarcoidosis. Am J Med 1975;59:365-72.
20. Bénéteau-Burnat B, Baudin B. Angiotensin-converting enzyme: clinical applications and laboratory investigations on serum and other biological fluids. Crit Rev Clin Lab Sci 1991;28:337-56.
21. DeRemee RA, Rohrbach MS. Serum angiotensin converting enzyme activity in evaluating the clinical course of sarcoidosis. Ann Intern Med 1990;92:361-5.
22. Allen RK, Pierce RJ, Barter CE. Angiotensin converting enzyme in bronchoalveolar lavage fluid in sarcoidosis. Sarcoidosis 1992;9:54-9.
23. Gorrell MD, Wickson J, McCaughan GW. Expression of the rat CD26 antigen (dipeptidyl peptidase IV) on subpopulations of rat lymphocytes. Cell Immunol 1991;134: 205-15.
24. Laouar A, Bauvois B. Characterization and modulation of cell surface proteases of human myeloblastoid (HL-60) cells and comparison to normal myeloid cells. Immunol Lett 1992; 34:257-65.
25. Jackman HL, Tan F, Schraufnagel D, Dragovic T, Dezsö B, Becker RP, Erdös EG. Plasma membrane-bound and lysosomal peptidases in human alveolar macrophages. Am J Respir Cell Mol Biol 1995;13:196-204.
26. Proud D, Subauste C, Ward P. Glucocorticoids do not alter peptidase expression on an human bronchial cell line. Am J Respir Cell Mol Biol 1994;11:57-65.
27. Vanham G, Kestens L, De Meester I, et al. Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects. JAIDS 1993; 6:749-57.
28. Saiki I, Fuji H, Yoneda J, et al. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 1993;54:137-43.
29. Hoogsteden HC, van Hal PT, Wijkhuijs JM, Hop W, Hilvering C. Differences in expression of monocyte/macrophage surface antigens in peripheral blood and bronchoalveolar cells in interstitial lung diseases. Lung 1993;171: 149-60.
30. Rohrbach MS, Conrad AK. Comparison of the T lymphocyte-dependent induction of angiotensin converting enzyme and leucine aminopeptidase in cultured monocytes. Clin Exp Immunol 1991;83:510-5.
31. Soderberg C, Larsson S, Bergstedt-Lindqvist S, Muller E. Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol 1993;67:3166-75.
32. Delmas B, Gelfi J, L'Haridon R, et al. Aminopeptidase N is a major receptor for the enteropathogenic coronavirus TGEV. Nature 1992;357:417-20.
33. Yeager CL, Ashmum RA, Williams R, et al. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 1992;357:420-2.